Generex BiotechnologyGNBTQ
13F holders, Q1 2026 (March 31)2holders +1
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding Generex Biotechnology Corp. (GNBTQ) in their 13F filings, up 1 from Q4 2025. 0 opened new positions and 0 sold out. The largest holders were NBT Bank, N.A. ($0) and Coston, McIsaac & Partners ($0).
- Company
- Generex Biotechnology Corp.
- CUSIP
- 371485301
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 235 shares bought, net +235 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| NBT Bank, N.A. | 0.00% | Add +0.0% | 235 | $0 |
| Coston, McIsaac & Partners | 0.00% | No change | 28,572 | $0 |
"% of holder's portfolio" is GNBTQ's weight in each manager's 13F, not the share of Generex Biotechnology Corp. the manager owns.